The decision is a major victory for the Biden administration, which appealed a recent U.S. Court of Appeals for the Fifth Circuit decision that the FDA's actions easing access to mifepristone were unlawful.
June 13, 2024 at 10:36 AM
3 minute read
The U.S. Supreme Court on Thursday unanimously rejected a lawsuit challenging the federal Food and Drug Administration’s loosening of restrictions on the common abortion drug mifepristone, holding that a group of anti-abortion doctors lacks legal standing to bring the challenge.
Justice Brett Kavanaugh wrote the opinion for the court. Justice Clarence Thomas joined Kavanaugh and issued a concurrence.
Presented by BigVoodoo
The National Law Journal Elite Trial Lawyers recognizes U.S.-based law firms performing exemplary work on behalf of plaintiffs.
The National Law Journal honors attorneys & judges who've made a remarkable difference in the legal profession in the D.C. area.
GlobeSt. Women of Influence Conference celebrates the women who drive the commercial real estate industry forward.
Cullen and Dykman is seeking an associate attorney with a minimum of 5+ years in insurance coverage experience as well as risk transfer and ...
McCarter & English, LLP is actively seeking a midlevel insurance coverage associate for its Newark, NJ and/or Philadelphia, PA offices. ...
McCarter & English, LLP, a well established and growing law firm, is actively seeking a talented and driven associate having 2-5 years o...
Breaking news and trends for law firm and legal departments about the evolving federal regulations in a volatile political climate.
Credit: Carl/Adobe Stock
